For Information Contact:
Erchonia Corporation
2021 Commerce Drive
McKinney, TX 75071
ATT: Charlie Shanks
VP, Sales and Marketing
214.733.5203
cshanks@erchonia.com
Erchonia Corporation, a world leader in the research, design, development, and manufacturing of low-level lasers announced that the US Food and Drug Administration has approved its 4L™ laser for use during liposuction.
The Erchonia 4L™ laser is the first and only low-level laser approved for use during liposuction. The painless laser treatment is administered a few minutes prior to liposuction and works by liquefying the fat. As a result, fat removal is made easier and quicker. There is less post-op pain and bruising and a speedier recovery time. In addition less pain medication is required.
The FDA approved the laser based on the results of an IRB approved, multi-center, double blind, randomized study. The comparison between the actively treated patients and the placebo-treated patients resulted in an impressive difference between groups in degree of pain. Significant differences in emulsification of fat, ease of extraction, and amount of swelling were also recorded.
“This approval is a major step forward in our goal to establish the Erchonia 4L™ laser as the future of liposuction,” comments Charlie Shanks, VP of Sales and Marketing for Erchonia Corporation. “We believe that eventually patients will demand laser-assisted liposuction over traditional methods because of the amazing post-operative benefits.”
Erchonia was founded in 1996 and is dedicated to advancing the science of health through the development of superior bio-medical laser products. Recently, Erchonia moved into a new state of the art facility where research, development, fabrication and assembly of goods are completed in-house. Erchonia also has FDA approval on the use of their lasers for therapeutic healing.
The Erchonia laser is currently being used by approximately 100 cosmetic and plastic surgeons. To find a surgeon or for more information on Erchonia, visit www.erchonia.com.
For Information Contact:
Charlie Shanks
VP Sales & Marketing
(480) 633-3129
cshanks@erchonia.com
FOR IMMEDIATE RELEASE:
Erchonia Medical, Inc. announces that on June 8, 2004 the United States Patent Office issued U.S. Patent No. 6,746,473 to Erchonia Medical, Inc. covering all hand-held laser devices with more than one laser.
This enables Erchonia Medical, Inc., to offer the only patented, handheld, true multi-laser devices as compared to various other “multi-LED” devices that often claim to be lasers, when in fact, they are not. Multi-diode laser components enhance the efficiency and effectiveness of the devices in which they are utilized.
“This patent is a testament to Erchonia’s continuing commitment to be the world leader in low level laser technology and to consistently push the boundaries of physics, technology and medical applications to seek the answers to human pain and suffering,” states Charlie Shanks, VP of Sales and Marketing.
“Erchonia has consistently lead the world in state-of-the-art healing laser technology and manufacturing, from our very earliest products to our present PL4000 and PL5000 lasers that are in use throughout the world today.”
“Erchonia was the very first low level laser manufacturer to receive the FDA’s 510(k) market clearance for the treatment of chronic pain, and in addition to this patent, Erchonia is anticipating a second FDA clearance this summer,” says Mr. Shanks.
Erchonia 3LT™ Lasers are small hand held devices that are being utilized by health care professionals and professional sports organizations worldwide for the treatment of a wide range of conditions from acute and chronic pain to wound and burn healing.
Erchonia Medical, Inc., is the world leader in the research, design and manufacturing of Low Level Lasers and proudly displays the MADE IN THE USA label on all of their products produced at their world headquarters in Mesa, AZ.
About Erchonia
Founded in 1996 to advance the art and science of health through the development, and distribution of superior Erchonia® 3LT™ lasers. Erchonia is dedicated to the highest quality standards, evidenced by their ISO 9000 and ISO 13000 manufacturing standards. They have built an impeccable reputation in the sports market, working with several professional organizations such as the New York Jets, Kansas City Chiefs, Philadelphia 76ers and the Milwaukee Brewers to name a few. Erchonia’s manufacturing facility is located at 4751 E. Indigo Street, Mesa, AZ 85205. All parts of the Erchonia® 3LT™ Laser are made in the USA.
For more information on Erchonia, please visit their web site at www.erchonia.com.
6 NEWS – First at 5:00 – Dr. Robert Jackson, clinical trial principal investigator, talks about Zerona™ and the results shown in the study.
Has the day finally come when you can shed fat without diet, exercise, or surgery? Possibly. Expecting FDA clearance this summer is Zerona, a noninvasive, pain-free laser that claims to stimulate the release of fat from cells, which is then absorbed by the lymphatic system and naturally excreted from the body. A recent clinical study has shown an average reduction of 3.65 inches from the waist, hips, and thighs after two weeks of six 40-minute treatments. \”This goes way beyond plastic surgery,\” says Frank Ryan, a board-certified plastic surgeon in Beverly Hills who has been using the laser. \”It\’s a game changer that revolutionizes the field.\” Adds Celeste, 54, who has had the treatment, \”In two weeks, I lost about 1.5 inches on each thigh. My clothes fit better now.\” The downside? Nobody knows yet how long the results last or any potential long-term side effects. Prices will average $500 per session.
Bookmark/Search this post with
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish